BABYDUST METHOD LLC, THE

BabyDust Method LLC specializes in in vitro diagnostic (IVD) kits designed for rapid immunochromatographic testing (ICT). Their products focus on detecting reproductive hormones, specifically luteinizing hormone (LH) and total human chorionic gonadotropin (hCG), in patient samples. These kits are formatted as point-of-care tools, primarily used for fertility and pregnancy monitoring in clinical settings.

BabyDust Method LLC is based in the United States. The company’s operations and regulatory compliance align with U.S. medical device standards, including FDA requirements.

BabyDust Method LLC’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and compliance with U.S. medical device regulations, allowing for standardized identification and tracking of their products.

BabyDust Method LLC’s IVD kits are classified under two FDA device classes: Class I and Class II. The classification depends on factors like the intended use, risk level, and regulatory pathway. Class I devices generally pose minimal risk, while Class II devices require additional controls to ensure safety and effectiveness.